MOTS-c
MOTS-c, explained.
MOTS-c is a mitochondrial-derived peptide studied in longevity and metabolic-health research. PepEasy gives you a clean place to understand what it is, how it's thought to work, and what the evidence does — and doesn't — show in humans.
Educational only — not medical advice. Consult a qualified licensed provider.
MOTS-c is a 16-amino-acid mitochondrial-derived peptide encoded within the 12S rRNA region of mitochondrial DNA. In animal studies it has been investigated as an activator of AMPK in the context of insulin sensitivity, glucose uptake, and exercise capacity, which is why it is studied in metabolism and longevity research. Native MOTS-c has no completed human trials and is not FDA-approved. It is sold only as a research chemical.
What MOTS-c is
MOTS-c (Mitochondrial Open reading frame of the Twelve-S rRNA type-c) is a short peptide of 16 amino acids — but what makes it unusual is where it comes from. Most peptides are encoded by your nuclear DNA; MOTS-c is encoded inside the mitochondrial genome, in the 12S ribosomal RNA region. That puts it in a small, much-studied class called mitochondrial-derived peptides (MDPs), alongside humanin and the SHLP family. It was first described in a 2015 Cell Metabolism paper, and the sequence is highly conserved across species — the first 11 residues are nearly identical in humans and mice — which is part of why researchers took it seriously as a signaling molecule rather than a fragment. Worth being precise about the human evidence: native MOTS-c itself has no completed human clinical trials, though a separate engineered MOTS-c analog (CohBar's CB4211) did complete an early Phase 1a/1b safety study — that analog is not the same molecule sold online. MOTS-c itself is commercially sold only as a research chemical for laboratory use, not as an approved medicine.
How MOTS-c is thought to work
MOTS-c is best understood as a metabolic stress signal. The headline mechanism is activation of AMPK (AMP-activated protein kinase), the cell's master energy sensor — when AMPK switches on, cells take up more glucose, burn more fat, and build more mitochondria. In skeletal muscle, MOTS-c is reported to increase GLUT4 glucose transporters and boost glucose uptake, and it appears to interfere with the folate cycle and de novo purine synthesis upstream of AMPK. Under metabolic stress it can move out of the mitochondria and into the cell nucleus, where it interacts with stress-response transcription factors (the NRF2/antioxidant-response pathway) to switch on protective genes. It's often framed as an 'exercise-mimetic': one widely cited 2021 study (Reynolds et al., Nature Communications) reported that exercise itself raises MOTS-c roughly 12-fold in muscle, and that MOTS-c levels decline with age. Important caveat — nearly all of this mechanistic work is from cell and animal models, not humans.
Areas of research interest
- Insulin sensitivity and glucose metabolism — its most-studied area in animal models
- Metabolic health and body composition, where rodent studies examined diet-induced obesity
- Exercise capacity and endurance, given its 'exercise-mimetic' framing in preclinical work
- Longevity and aging, since levels fall with age and it activates AMPK in animal studies
- Mitochondrial function and cellular stress responses via the AMPK/NRF2 pathways
Side effects & safety
The honest summary: MOTS-c's safety in humans is essentially unknown. USADA states plainly that 'it is unknown under what conditions (if any) it is safe to use MOTS-c because there are no completed clinical trials,' and there is no long-term human safety data of any kind. Effects reported anecdotally by online users — not from controlled studies — include increased heart rate, injection-site irritation, insomnia, and fever. Because it's sold as a research chemical, purity, sterility, and actual peptide content are not guaranteed and can vary vial to vial, adding contamination risks on top of the unknown biology. Because animal studies report interactions with insulin sensitivity and glucose handling, this is an area researchers flag as relevant to anyone managing diabetes or on glucose-lowering medication. This is not medical advice — talk to a qualified licensed provider before considering anything in this space.
MOTS-c vs related metabolic & longevity peptides
| MOTS-c | Tesamorelin | MK-677 (ibutamoren) | |
|---|---|---|---|
| Class | Mitochondrial-derived peptide | GHRH analog (peptide) | Oral GH secretagogue (non-peptide) |
| Primary research area | Metabolism, insulin sensitivity, exercise | Visceral fat, GH/IGF-1 | Appetite, GH/IGF-1, body composition |
| Main mechanism | AMPK activation | Stimulates pituitary GH release | Mimics ghrelin to raise GH |
| FDA approval | None | Approved (HIV lipodystrophy) | None (investigational) |
| Human clinical trials | None completed | Randomized controlled trials | Multiple trials |
| Banned in sport (WADA) | Yes — AMPK activator, S4.4 | Yes — hormone modulator | Yes — GH secretagogue, S2 |
Regulatory status
MOTS-c is not approved by the FDA for any use, and native MOTS-c has no completed human clinical trials. It is sold almost exclusively under 'for research purposes only — not for human use' labeling, and USADA explicitly cautions that being available for sale online doesn't make a product safe or legal. It is also prohibited in sport: the World Anti-Doping Agency lists MOTS-c under metabolic modulators (S4.4, AMPK activators), banned at all times. Because it is distributed as an unregulated research chemical, purity, sterility, and actual peptide content are not guaranteed and can vary. This page is educational and is not medical advice — anyone with questions about their health should consult a qualified licensed provider.
How PepEasy helps
Learn it
Get clear, cited, honestly-graded answers about MOTS-c — what the animal evidence actually shows, what's still unproven in humans, and how it's classified.
Understand the evidence
See where the science is preclinical versus human, what's FDA-approved versus research-only, and what remains unknown — so you can have an informed conversation with a licensed provider.
Frequently asked
What are MOTS-c side effects?+
Human safety data is essentially nonexistent. Anecdotal reports — not controlled studies — mention increased heart rate, injection-site irritation, insomnia, and fever. There is no long-term safety data, and research-chemical purity is not guaranteed. This is information, not medical advice — consult a licensed provider.
Is MOTS-c a steroid?+
No. MOTS-c is a 16-amino-acid mitochondrial-derived peptide that works through the AMPK energy-sensing pathway, not an anabolic steroid. It is not designed to build muscle the way steroids do.
Is MOTS-c FDA approved or safe?+
It is not FDA-approved for any use, and native MOTS-c has no completed human clinical trials, so its safety is unknown. (A separate engineered analog, CB4211, completed an early Phase 1 study — not the same as the MOTS-c sold online.) It's sold only as a research chemical 'not for human use.' This is information, not medical advice — consult a clinician.
Is MOTS-c banned in sports?+
Yes. The World Anti-Doping Agency lists MOTS-c under metabolic modulators (S4.4, AMPK activators), prohibited at all times. USADA notes athletes cannot get a Therapeutic Use Exemption for it because it has no approved therapeutic use.
What is MOTS-c compared to or paired with?+
It's often discussed alongside other metabolic and longevity peptides like tesamorelin and MK-677, and the SS-31/Elamipretide mitochondrial crowd. Unlike tesamorelin, MOTS-c has no human trials or FDA approval — a key difference to keep in view.
Everything peptides, made easy.
Join PepEasy and get the tools, the knowledge, and the care — in one place.
Explore more